Phase I Expansion of Olaparib (PARP Inhibitor) and AZD5363 (AKT Inhibitor) in Recurrent Ovarian, Endometrial and Triple Negative Breast CancerS. Westin,J. Litton, R. Williams,P. Soliman,M. Frumovitz,K. Schmeler,A. Jazaeri,A. Sood,K. Lu,S. Moulder,R. Murthy,A. Rodriguez, C. Samuel, L. Engerman,A. Cyriac,P. Rugman,J. Lindemann,E. McMurtry,G. Mills,R. ColemanANNALS OF ONCOLOGY(2017)引用 13|浏览52AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要